resourceId,resourceName,resourceType,synonyms,rrid,description,aiSummary,usageRequirements,howToAcquire,dateAdded,dateModified,animalModelId,antibodyId,cellLineId,geneticReagentId,biobankId,_pmid,_doi,_publicationTitle,_year,_confidence,_toolType
a2e8a2a7-8ca9-55f3-a360-83c729440728,3D rBM overlay model,Advanced Cellular Model,,,,,,,,,,,,,,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.85,advanced_cellular_model
fa394cc7-9f63-5714-af1b-4240eaa62112,cNF organoids,Advanced Cellular Model,,,,,,,,,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,0.95,advanced_cellular_model
4f95c143-9441-51a0-ab5b-e8f5b7cdac0f,spheroid culture system,Advanced Cellular Model,,,,,,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,advanced_cellular_model
14313702-6f1d-53aa-9e69-b743cca3438d,TAME chips,Advanced Cellular Model,,,,,,,,,,,,,,PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,0.85,advanced_cellular_model
9c816cb8-6187-5283-95bb-c35bca36e57a,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,Animal Model,,,,,,,,,,,,,,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,0.95,animal_model
56436cb7-cfed-5976-9200-23f810a66b9c,2.3-kb α1(I) collagen-cre Nf1 flox/flox,Animal Model,,,,,,,,,,,,,,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.85,animal_model
b1c5c572-3b5c-52a6-a910-33321c4f1828,4/FM7; T80-Gal4 y w Mer4,Animal Model,,,,,,,,,,,,,,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.85,animal_model
ac709e73-9f67-5ce8-9835-bd64d2f50993,9a−/9a− Nf1,Animal Model,,,,,,,,,,,,,,PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,0.9,animal_model
92d2e667-6bf8-5dcc-9f16-9a6f2c08394a,C57BL6/J Nf1+/−;Trp53+/−,Animal Model,,,,,,,,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,0.95,animal_model
866607df-5a44-5eae-9b1e-8d6411ecb745,cisNP,Animal Model,,,,,,,,,,,,,,PMID:38502231 | PMID:34010628,10.1172/JCI176748 | 10.1016/j.stem.2021.04.029,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model
f5cbd630-c2a5-5c55-8dd6-7db2cda555e9,"Dhh::Cre, Nf1fl/fl, Pten",Animal Model,,,,,,,,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,animal_model
b8f5e9c2-6b81-5c2b-bc67-44eaa3d0cc72,DhhCre,Animal Model,,,,,,,,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,animal_model
2f569e31-8ff7-54e8-b684-176b4df47f50,DhhCre;Nf1f/f;Luciferase,Animal Model,,,,,,,,,,,,,,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.85,animal_model
58b5ecc6-5290-5dc9-aa53-358a7a70fad1,DhhCre;Nf1fl/fl,Animal Model,,,,,,,,,,,,,,PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,,0.95,animal_model
f03b3b12-dc42-540a-8105-3147d425fb1f,H7;Nf1mut,Animal Model,,,,,,,,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.9,animal_model
f3355321-fa18-5f7e-8f14-d892385d821a,hGFAP-cre,Animal Model,,,,,,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
b9bf1586-64f3-584d-ac39-70ab47e7832d,L7-cre,Animal Model,,,,,,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
fdfe318a-0b2d-54d2-87e4-66a0f4e6ad04,Math1-cre,Animal Model,,,,,,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
cd685fab-cc29-5bfc-bb21-77237036daeb,Nestin-creER,Animal Model,,,,,,,,,,,,,,PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.9,animal_model
59983fe4-e778-519b-b91e-eb1331dfc1ad,Nf1 c.5425 C > T ; Arg1809Cys,Animal Model,,,,,,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model
32bf181d-ea22-556e-b56b-cc54d16a4ab7,Nf1 f/neo ; hGFAP-Cre,Animal Model,,,,,,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model
cb2faad8-e4ab-54ab-9286-f4f4544b40f5,Nf1 fcr,Animal Model,,,,,,,,,,,,,,PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,0.95,animal_model
cba9e7f2-5307-57c3-a000-be83339d7221,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,Animal Model,,,,,,,,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,animal_model
ba5ab76b-b23e-5258-9d61-886f4ab09510,Nf1 flox,Animal Model,,,,,,,,,,,,,,PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:21726432 | PMID:32839340 | PMID:18242513,10.1002/jcsm.12632 | 10.1002/ajh.22035 | 10.1158/0008-5472.CAN-10-4577 | 10.1186/1741-7015-9-82 | 10.1073/pnas.2008391117 | 10.1016/j.ccr.2008.01.003,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. | Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1. | Brain-wide structural and functional disruption in mice with oligodendrocyte-specific | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,0.95,animal_model
0e503f20-aacd-5634-a510-d313b55dc81f,Nf1 flox/flox ; Hoxb7-Cre,Animal Model,,,,,,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,animal_model
4a5e5e77-eb10-5cbf-bc35-521ffdda67f4,Nf1 flox/flox; GFAP-Cre,Animal Model,,,,,,,,,,,,,,PMID:21216928 | PMID:26883872 | PMID:20551058,10.1158/1535-7163.MCT-10-0654 | 10.1016/j.jprot.2016.02.004 | 10.1158/0008-5472.CAN-09-3769,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. | 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,0.95,animal_model
66988b6a-7f49-5b92-b5cf-58db189fc582,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",Animal Model,,,,,,,,,,,,,,PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,0.95,animal_model
8948e47d-3bbf-5cb8-ba55-74c15a4f3e96,Nf1 hGFAP CKO,Animal Model,,,,,,,,,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.95,animal_model
a4552f3c-0475-5da9-81fa-9e9b89c1b6a0,Nf1 NcreER CKO,Animal Model,,,,,,,,,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.9,animal_model
9f90706d-5b59-553d-9743-1eb6dbc61c5d,NF1 R1947/+,Animal Model,,,,,,,,,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.95,animal_model
2f1c5933-8ac9-5f7d-a7e1-60f4eded55c2,NF1 R1947X minipig,Animal Model,,,,,,,,,,,,,,PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,0.95,animal_model
359e011a-d18d-5ec9-9e8b-1b264e17c46c,Nf1(flox/-);Col2.3Cre(+),Animal Model,,,,,,,,,,,,,,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,0.95,animal_model
b7cbe81f-e9db-5fab-9564-521b0c878ecf,Nf1(ob) (-/-),Animal Model,,,,,,,,,,,,,,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.9,animal_model
9c821f99-a92d-5fcc-b512-8607480ae168,Nf1+/-,Animal Model,,,,,,,,,,,,,,PMID:32781282 | PMID:21199799 | PMID:8582272 | PMID:21949590 | PMID:40590220 | PMID:36890585 | PMID:40684195 | PMID:23071067 | PMID:26190969 | PMID:21439418 | PMID:25772366 | PMID:29847659 | PMID:18242513 | PMID:28525381 | PMID:16835260 | PMID:18632543,10.1016/j.trsl.2020.08.001 | 10.1158/0008-5472.CAN-10-2732 | 10.1242/dev.121.11.3583 | 10.2478/v10134-010-0025-8 | 10.1172/JCI188932 | 10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1158/0008-5472.CAN-12-1728 | 10.3389/fncel.2015.00234 | 10.1016/j.bone.2011.03.760 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1016/j.ccr.2008.01.003 | 10.18632/oncotarget.17589 | 10.1093/hmg/ddl165 | 10.1001/jama.300.3.287,"Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. | Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. | In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.",,0.95,animal_model
edade01d-5b28-5d39-b592-a2355cac456a,Nf1+/− GFAP CKO,Animal Model,,,,,,,,,,,,,,PMID:21963652 | PMID:19191334 | PMID:23225063 | PMID:25772366,10.1016/j.expneurol.2011.09.005 | 10.1002/glia.20845 | 10.1002/ana.23793 | 10.1016/j.celrep.2015.02.041,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,0.95,animal_model
0a5050bc-6f25-584d-94ef-06f1f9dd8eb0,Nf1-Arf flox/flox ;Postn-Cre,Animal Model,,,,,,,,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,animal_model
9ef4e72f-27a8-5a62-898e-da5059be3278,Nf1-IF,Animal Model,,,,,,,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.95,animal_model
badc395b-6692-5782-b3e4-00d8fd731040,Nf1-IFPS,Animal Model,,,,,,,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.95,animal_model
db1873f0-9852-563e-b595-a46452d0b540,Nf1-PS,Animal Model,,,,,,,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.95,animal_model
3f1d08b5-7f28-5444-b71f-adb4546b3066,Nf1/p53-/-,Animal Model,,,,,,,,,,,,,,PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,0.9,animal_model
bd9636e4-d1b2-5181-a19b-29cd24f4f64d,Nf1Col1,Animal Model,,,,,,,,,,,,,,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,0.95,animal_model
40599842-43f7-5565-b886-5dc649e0d30d,Nf1Dsk9/+,Animal Model,,,,,,,,,,,,,,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,0.95,animal_model
22f30826-2dc3-5a19-a9b6-22427fdbcd0b,Nf1f/f;Trp53f/f;CGD,Animal Model,,,,,,,,,,,,,,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model
019086d3-2877-507f-946f-4a350906b3c5,Nf1f/f;Trp53f/f;Nes-TK,Animal Model,,,,,,,,,,,,,,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,0.9,animal_model
d835ef05-a6e7-5269-adec-43e288108932,Nf1fl/fl;DhhCre,Animal Model,,,,,,,,,,,,,,PMID:28256556 | PMID:26904939,10.1038/srep43315 | 10.1016/j.celrep.2016.01.074,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,0.95,animal_model
2433f01f-8ef3-514a-978a-93a449dcc8b4,Nf1flox/flox,Animal Model,"Nf1 fl/fl, Nf1 flox/flox, Nf1fl/fl",,,,,,,,,,,,,PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958 | PMID:34040258,10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1002/glia.20845 | 10.1016/j.bone.2011.03.760 | 10.1117/1.JBO.26.12.125001 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1371/journal.pone.0190001 | 10.18632/oncotarget.17589 | 10.7554/eLife.05151 | 10.1002/jbmr.42 | 10.1038/s41586-021-03580-6,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts. | NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.95,animal_model
c1738be3-7190-5eed-8f1e-44c26b7840cf,Nf1flox/flox; Olig2-Cre,Animal Model,,,,,,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
9831ac31-0d36-5fac-9acf-a05868bb41cf,Nf1flox/flox; Prom1-CreER,Animal Model,,,,,,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
6303a527-7a77-5149-a18b-479f76908051,Nf1flox/flox;Arf flox/flox;PostnCre+,Animal Model,,,,,,,,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,animal_model
b28a9b9d-7cad-566a-af24-fabd2d1c9444,Nf1flox/flox;PostnCre,Animal Model,,,,,,,,,,,,,,PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282,10.1038/s41591-020-01193-6 | 10.1158/1535-7163.MCT-19-0123 | 10.1038/s41416-021-01270-8 | 10.1158/1078-0432.CCR-23-2548,"Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.",,0.95,animal_model
1bd5aaf0-4cc3-592c-897a-9e801384b9b6,Nf1flox/mut,Animal Model,,,,,,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
72b463a4-9450-5933-9ee9-144f93c2e642,Nf1flox/mut; Olig2-Cre,Animal Model,,,,,,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
c4168bda-acf2-50c3-b7a4-adf9290dab55,Nf1flox/mut; Prom1-CreER,Animal Model,,,,,,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
3a865aff-eb92-5ed3-a87b-6ccc9db254fe,Nf1flox/mut;GFAP-Cre,Animal Model,,,,,,,,,,,,,,PMID:24375753 | PMID:20551058 | PMID:28525381,10.1002/ana.24093 | 10.1158/0008-5472.CAN-09-3769 | 10.18632/oncotarget.17589,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.95,animal_model
5ffaafc6-5cfc-5ef4-b3fd-e89ad69b4560,Nf1flox/wt,Animal Model,,,,,,,,,,,,,,PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,0.9,animal_model
d6ef2a65-bc56-578e-a426-a8e42388839b,Nf1Prx1-/-,Animal Model,,,,,,,,,,,,,,PMID:34935315 | PMID:24465906 | PMID:21726432,10.1117/1.JBO.26.12.125001 | 10.1371/journal.pone.0086115 | 10.1186/1741-7015-9-82,"Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.",,0.95,animal_model
a0443d94-cf21-5ff9-bea5-10c21c67b6e7,Nf2 flox2/flox2 ;p16 Ink4a*/*,Animal Model,,,,,,,,,,,,,,PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,0.95,animal_model
54f66d81-ea33-5c3e-b5c9-763b915539d1,Nf2+/-,Animal Model,,,,,,,,,,,,,,PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,0.85,animal_model
95087676-d95f-5986-8a19-a7491d31d4f7,Nf2flox/flox,Animal Model,"Nf2 fl/fl, Nf2 flox/flox, Nf2 flox2/flox2, Nf2fl/fl",,,,,,,,,,,,,PMID:41444363 | PMID:24817309 | PMID:17924978 | PMID:38945076,10.1038/s41598-025-32031-9 | 10.1371/journal.pone.0097320 | 10.1111/j.1750-3639.2007.00105.x | 10.1016/j.redox.2024.103249,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner. | Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,0.9,animal_model
f8ad311d-5503-5185-8331-bb3622c60dda,NPcis,Animal Model,,,,,,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,animal_model
03d2ffe3-ea87-5e39-894c-adc7cb5da85d,OPG Nf1fl/mut (Nf1+/−),Animal Model,,,,,,,,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.9,animal_model
61ef5af3-9ee1-551b-a8d2-4b6cbee11331,Osx-/-Nf1flox/flox,Animal Model,,,,,,,,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.85,animal_model
4f21943c-ea3d-5020-849d-053e3e34536c,"Osx-tTA,tetO-cre;Nf1flox/flox",Animal Model,,,,,,,,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.85,animal_model
6aed20e7-7783-549b-8c58-ba167a441fdc,P0-CRE,Animal Model,,,,,,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.85,animal_model
b25925a3-6f19-5e5b-be0c-42a0782b9c79,P0SchΔ39-121,Animal Model,,,,,,,,,,,,,,PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,0.95,animal_model
680350a0-4047-53d0-a656-b2023afec10d,Periostin-CRE;NF2 fl/fl,Animal Model,,,,,,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,animal_model
707cc2cc-7915-5ee8-8ff5-909b0be068fd,Periostin-CRE;NF2 fl/fl TAZ fl/fl,Animal Model,,,,,,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,animal_model
2db4c5f8-aa40-5224-8496-b01342a63231,Periostin-CRE;NF2 fl/fl YAP fl/fl,Animal Model,,,,,,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,animal_model
64c128f0-d5ad-571d-a6d2-4a466d982210,PLP CreERT2; Nf1 f/−; ROSA-LacZ,Animal Model,,,,,,,,,,,,,,PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,,0.95,animal_model
912ab836-55cc-5769-bab0-ad1201b989f4,Postn-Cre; Nf2flox/flox,Animal Model,,,,,,,,,,,,,,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,0.95,animal_model
2b37cdeb-3836-52bd-a2a5-a229d9b507b0,Postn-cre;Nf2f/f,Animal Model,,,,,,,,,,,,,,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,0.95,animal_model
06ff776b-fea8-54f5-b727-9abca4ce187d,P{ KK101909 }VIE‐260B,Animal Model,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,animal_model
4027ec9e-7379-583a-99a1-69db7e0df51e,R681X Nf1,Animal Model,,,,,,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,animal_model
5ad65882-986b-5a72-86a2-69e3b6d8a5c6,Stat3(fl/fl);Nf1(fl/fl);DhhCre,Animal Model,,,,,,,,,,,,,,PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,0.9,animal_model
61dad128-c400-5e13-b462-a5c01a5644b6,TetOff-Osx-/-Nf1,Animal Model,,,,,,,,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.9,animal_model
40149ff0-d3d4-5803-bd93-aa74eca79655,Tg(U6x:nf2a/b-4sgRNA),Animal Model,,,,,,,,,,,,,,PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,0.95,animal_model
5eb80e47-0cdb-5b04-ba4d-98e4c6d6a91c,"Trp53, Nf1, Suz12 triple mutant",Animal Model,,,,,,,,,,,,,,PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,0.95,animal_model
38365203-9446-583d-a77b-e07fb3a87d2b,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,Animal Model,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,animal_model
ce320a62-9c23-56c1-a31e-86a5bd53bbb8,y w Mer4,Animal Model,,,,,,,,,,,,,,PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.9,animal_model
fae3b1bf-8502-5691-8f76-fe7d992ddf9b,anti-Drosophila neurofibromin,Antibody,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,antibody
464c8e1c-ac32-5a1e-8e01-b6d81c6b4ae7,anti-human neurofibromin,Antibody,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,antibody
be3f5cac-fb6a-52dd-87b5-81f6624de84e,anti-Merlin,Antibody,,,,,,,,,,,,,,PMID:32457840 | PMID:20195187 | PMID:21072183 | PMID:31015291 | PMID:28126595 | PMID:29715273 | PMID:30274821 | PMID:39415595 | PMID:38945076 | PMID:24595234,10.3389/fonc.2020.00687 | 10.1097/MAO.0b013e3181d2777f | 10.1371/journal.pone.0013791 | 10.1126/scisignal.aau8749 | 10.1016/j.ebiom.2017.01.020 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.1242/dmm.050862 | 10.1016/j.redox.2024.103249 | 10.1371/journal.pone.0090853,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling. | Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.",,0.95,antibody
3f1626c9-c2df-5a77-9deb-205bc8bb48e3,anti-neurofibromin,Antibody,,,,,,,,,,,,,,PMID:38216123 | PMID:38481529 | PMID:37446790 | PMID:39890807 | PMID:29438698 | PMID:29847659 | PMID:36241865,10.1016/j.molmet.2024.101876 | 10.3389/fcell.2024.1359561 | 10.3390/molecules28135128 | 10.1038/s41598-024-84493-y | 10.1016/j.ccell.2018.01.005 | 10.1167/iovs.17-22588 | 10.1038/s12276-022-00850-9,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,0.95,antibody
d678293f-040f-5154-9d48-6044b75a47ff,anti-neurofibromin 1,Antibody,,,,,,,,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.95,antibody
7aa09144-6af2-5804-89f9-465a356fcdfb,anti-neurofibromin/NF1,Antibody,,,,,,,,,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.95,antibody
45750d0f-8efd-58e6-b6e2-92689dddc7c6,anti-NF1,Antibody,,,,,,,,,,,,,,PMID:41022755 | PMID:28166733 | PMID:38714355 | PMID:39472976 | PMID:41564118 | PMID:30479396 | PMID:39129390 | PMID:34257279 | PMID:34011935 | PMID:25535838,10.1038/s41467-025-63619-4 | 10.1186/s12864-017-3519-7 | 10.1158/1535-7163.MCT-23-0510 | 10.1186/s40478-024-01875-z | 10.1371/journal.pone.0340183 | 10.1038/s41467-018-07452-y | 10.1002/1878-0261.13704 | 10.1038/s41467-021-24505-x | 10.1038/s41419-021-03802-9 | 10.7554/eLife.05151,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,0.95,antibody
d4eeae83-dd4f-5141-8e18-1068ba6bf9ff,anti-NF1GRP-D,Antibody,,,,,,,,,,,,,,PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,0.9,antibody
b0942d41-96e5-5773-948b-fbb48ec8e229,anti-NF2,Antibody,,,,,,,,,,,,,,PMID:29715273 | PMID:26219339,10.1371/journal.pone.0196726 | 10.18632/oncotarget.4858,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.9,antibody
9663b67b-42ed-599d-a232-4b230ad883c0,anti-NF2/merlin,Antibody,,,,,,,,,,,,,,PMID:33273014 | PMID:38216572 | PMID:19144871,10.1074/jbc.RA120.014960 | 10.1038/s41467-024-44755-9 | 10.3181/0809-RM-275,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,0.9,antibody
b5715407-fefe-5f38-b54f-c96df29d1a52,anti-phospho S518-Merlin,Antibody,,,,,,,,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,antibody
f73c4b7e-39e2-581d-8676-20fa3ca71aab,anti-phospho-Merlin,Antibody,,,,,,,,,,,,,,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,0.9,antibody
a692187c-b9f6-5fa5-9ec9-536b05f5a352,anti-S518-Merlin,Antibody,,,,,,,,,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,antibody
4bcc9f4f-aca1-530d-b0bf-5f797c48555c,anti-SUZ12,Antibody,,,,,,,,,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,0.9,antibody
35158f01-4e4f-5a4c-93cc-058b269bf7ce,17,Cell Line,,,,,,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
30a3a0f4-30d6-5d2c-a8cb-3f231d2fe2a3,2884,Cell Line,,,,,,,,,,,,,,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,0.9,cell_line
3047a0ba-ac89-58cf-800e-4e7c1680e207,2885,Cell Line,,,,,,,,,,,,,,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,0.9,cell_line
460c872a-9d2f-5138-96ec-d90b4c3c07d5,293FT,Cell Line,,RRID:CVCL_6911,,,,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.85,cell_line
e8626696-31a8-5ce5-85ba-eafdf85a9081,293T,Cell Line,"HEK 293T, HEK-293T, HEK293, HEK293T, NF1-null 293T, NF1-null HEK293T",,,,,,,,,,,,,PMID:31836666 | PMID:40590220 | PMID:35789380 | PMID:31836666 | PMID:29402968 | PMID:31015291 | PMID:40225167 | PMID:34415582 | PMID:39269317 | PMID:23175151 | PMID:38216587 | PMID:20554030 | PMID:28166733 | PMID:33934112 | PMID:33673681 | PMID:30531922 | PMID:36689660 | PMID:40025578 | PMID:25026211 | PMID:26219339,10.1074/jbc.RA119.010934 | 10.1172/JCI188932 | 10.1158/2159-8290.CD-21-1671 | 10.1074/jbc.RA119.010934 | 10.1038/s41598-018-20894-0 | 10.1126/scisignal.aau8749 | 10.1155/2023/9628049 | 10.1002/glia.24075 | 10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1038/s41467-023-40408-5 | 10.1016/j.jneuroim.2010.05.002 | 10.1186/s12864-017-3519-7 | 10.1038/s41419-021-03716-6 | 10.3390/cancers13050999 | 10.1038/s41591-018-0263-8 | 10.1073/pnas.2208960120 | 10.1186/s40478-025-01965-6 | 10.1016/j.ccr.2014.05.001 | 10.18632/oncotarget.4858,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. | Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of | The molecular landscape of glioma in patients with Neurofibromatosis 1. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.95,cell_line
a4765cbe-ba30-544b-b731-3818d93f6b5f,2V6.11,Cell Line,,RRID:CVCL_6355,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.85,cell_line
3b3f7ea5-3fb3-5674-9f21-01157693cfc0,3PNF_SiPSsv_MM_11,Cell Line,,RRID:CVCL_UN12,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
9b0a4c5f-a9d1-5418-96cc-961164037e28,5653,Cell Line,,,,,,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
7ab1a9a6-fbdd-5c18-8942-e94bfdf6ef28,5746,Cell Line,,,,,,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
be58e700-bdd6-5072-9b52-fb4f88c3eb7d,88-3,Cell Line,,RRID:CVCL_RA82,,,,,,,,,,,,PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,0.9,cell_line
2667d8da-de63-5e85-9ae9-59d00058b48d,90-8,Cell Line,,RRID:CVCL_1B47,,,,,,,,,,,,PMID:24824755 | PMID:20049725 | PMID:32642733 | PMID:18483311,10.1371/journal.pone.0096733 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
995f5d9c-d3eb-5dbf-822d-dd2a4bca5a8b,95.6,Cell Line,,,,,,,,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,cell_line
e2918a1d-a7d4-5193-a0f5-248ecba5c0af,A549,Cell Line,,,,,,,,,,,,,,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.85,cell_line
278b42a5-7b40-5c9d-bf08-b0a48350860b,AC-CRISPR,Cell Line,,,,,,,,,,,,,,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,0.85,cell_line
23d9a69b-945e-538c-8e8b-52b9b79983d0,AC007-hTERT,Cell Line,,,,,,,,,,,,,,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.9,cell_line
38bed69c-8c07-53f1-aa00-08c26becbb26,AC028,Cell Line,,,,,,,,,,,,,,PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,0.85,cell_line
d1386129-d898-53a6-97e0-9c5b440df5e9,AsPC-1,Cell Line,,RRID:CVCL_0152,,,,,,,,,,,,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line
a30cb5fb-b05b-5f83-bb30-996e8fbfc76c,B76,Cell Line,,RRID:CVCL_U442,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
7f3d32b3-ede5-5eb8-9a19-d166f7b27814,B8 fibroblasts,Cell Line,,,,,,,,,,,,,,PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.85,cell_line
6715cb90-7319-5955-bd46-b1d21da7f08f,Ben-Men-1,Cell Line,,RRID:CVCL_1959,,,,,,,,,,,,PMID:33273014 | PMID:28126595 | PMID:26219339 | PMID:36148553,10.1074/jbc.RA120.014960 | 10.1016/j.ebiom.2017.01.020 | 10.18632/oncotarget.4858 | 10.1093/brain/awac342,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,cell_line
3dc7da7a-91d2-56ae-af93-c1cea07d24a4,BJFF.6,Cell Line,,RRID:CVCL_VU02,,,,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,cell_line
c3833025-8a17-54ac-a1ec-57c9531dd2ce,BL21(DE3),Cell Line,,,,,,,,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
d1c9b566-0c52-5b23-9fce-761eed670430,BL21(DE3) Star,Cell Line,,,,,,,,,,,,,,PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,0.9,cell_line
34ebc8df-ab6a-570c-9a4d-1715a7c7f0e1,BRGN,Cell Line,,,,,,,,,,,,,,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.8,cell_line
e4854530-f8ed-5268-9ebc-1d61d77ab603,BxPc3,Cell Line,,RRID:CVCL_0186,,,,,,,,,,,,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,cell_line
ae2135e1-4d74-5f96-b026-ec9873d49eb2,C2C12,Cell Line,,RRID:CVCL_0188,,,,,,,,,,,,PMID:32383545 | PMID:37446790,10.15252/embr.201949117 | 10.3390/molecules28135128,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,0.85,cell_line
b0020082-8199-5bf0-93fd-7d29f2da1365,CCD-1112Sk,Cell Line,,RRID:CVCL_2769,,,,,,,,,,,,PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,,0.9,cell_line
09cb80ef-92ae-5763-90f6-4c104818f6e2,cis MPNST,Cell Line,,,,,,,,,,,,,,PMID:38502231 | PMID:35393510,10.1172/JCI176748 | 10.1038/s41418-022-00991-4,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,0.9,cell_line
6f3ef438-16e5-5ded-b91a-e0b3f8086c69,COS-7,Cell Line,,RRID:CVCL_0224,,,,,,,,,,,,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,0.9,cell_line
5b5c5912-0cf3-5631-8ba2-1c2e4a45c1ea,CT10,Cell Line,,,,,,,,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
d408830f-dc82-574d-b204-559ba820d989,CT11,Cell Line,,,,,,,,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
9af1d3b0-91b2-5461-af1d-209ef38629f4,CT12,Cell Line,,,,,,,,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
7f63a873-2316-525c-8db0-67a071e3fa44,Daoy,Cell Line,,RRID:CVCL_1167,,,,,,,,,,,,PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,0.85,cell_line
99a0ff7c-1a5f-5eb0-87da-fa7e21f9ceeb,DBTRG,Cell Line,,RRID:CVCL_1169,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
064964d4-f8ec-5add-a40c-3abad4aa78d1,DDLS,Cell Line,,,,,,,,,,,,,,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.8,cell_line
7750e324-2e59-5cb7-ba9a-71dc007bf88d,DH10Bac,Cell Line,,,,,,,,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
7480155a-57b0-57dc-922d-abf33faa35e1,DH5α bacteria,Cell Line,,,,,,,,,,,,,,PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,0.8,cell_line
ecc9f50b-8516-53ee-af1b-d0c996ab387f,dNF1‐KO,Cell Line,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line
8b24ba11-5bb2-5389-843f-6aec45ed87f5,Drosophila Schneider (S2R+),Cell Line,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,cell_line
be4fc082-9500-5bc9-9d17-9aa1444b22a1,DS-red STS26T,Cell Line,,,,,,,,,,,,,,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
8f78ce72-6d9c-590f-9091-ee42d875b5c5,E13.5 DRG neurosphere,Cell Line,,,,,,,,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.8,cell_line
89d138e5-0f23-56da-90b7-17213e525529,FC-1801,Cell Line,,,,,,,,,,,,,,PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,0.9,cell_line
4b532828-56be-5d3a-8a2f-0e288c8acfcf,FiPS,Cell Line,,,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
f7e2bb13-b9f5-5efc-a11e-4f2d3e0de0bb,GBM1,Cell Line,,RRID:CVCL_DG57,,,,,,,,,,,,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,0.9,cell_line
d96837ab-ca54-5f40-afd9-0b7ede0f172f,H1838,Cell Line,,RRID:CVCL_1499,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
012f42c4-0aaf-56e9-a583-60a3a15266fa,H358,Cell Line,,RRID:CVCL_1559,,,,,,,,,,,,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.8,cell_line
30ff5a2c-69e6-5a5f-b705-6ce3ecdda69c,HEI-193,Cell Line,,RRID:CVCL_7670,,,,,,,,,,,,PMID:21111000 | PMID:38216587 | PMID:30617350 | PMID:30274821,10.1016/j.jneumeth.2010.10.021 | 10.1038/s41467-023-40408-5 | 10.1038/s41596-018-0105-7 | 10.1016/j.ebiom.2018.09.042,"A novel imaging-compatible sciatic nerve schwannoma model. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.",,0.95,cell_line
db3db0ae-5a93-506d-bef3-17718bbb4158,HeLa,Cell Line,,RRID:CVCL_0030,,,,,,,,,,,,PMID:40590220 | PMID:36420221 | PMID:32383545,10.1172/JCI188932 | 10.1016/j.omtn.2022.10.026 | 10.15252/embr.201949117,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,0.95,cell_line
c4cd60d8-b8d3-5e23-8169-e9f9aa19c889,HFFs,Cell Line,,,,,,,,,,,,,,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line
ac9fd66a-4a56-56c7-935a-f6521a4ccbe5,HPDE H6c7,Cell Line,,,,,,,,,,,,,,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.85,cell_line
8381baf7-b584-5734-864d-6990e37ca550,HS-PSS,Cell Line,,RRID:CVCL_8717,,,,,,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
435d01d8-e503-5fba-a288-26f4c5a7c143,HS-Sch-2,Cell Line,,RRID:CVCL_8718,,,,,,,,,,,,PMID:32642733 | PMID:35511749,10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-21-0947,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
16b9df1e-b09c-5691-af15-0464246c2942,HSC1λ,Cell Line,,,,,,,,,,,,,,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,0.9,cell_line
762b37cf-abef-5668-ab53-d37ef4a0bcda,HSR-GBM1,Cell Line,,,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
cfcf7036-c25c-587f-8308-4d95cf988d38,hTERT ipn02.3 2λ,Cell Line,,,,,,,,,,,,,,PMID:37140985 | PMID:38127282,10.1172/JCI168227 | 10.1158/1078-0432.CCR-23-2548,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line
0d3202e9-a216-508d-bbd3-eff818fc855b,hTERT ipn02.3 2λ CRL‐3392,Cell Line,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,cell_line
bc5b871f-4310-5cbd-b4d7-6bc40e5ae7dd,hTERT ipNF05.5,Cell Line,,,,,,,,,,,,,,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,0.95,cell_line
9f3e8e84-4dae-5b7e-a500-10d297c4a08e,hTERT NF1 ipn02.3 2λ,Cell Line,,,,,,,,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line
9cac64e8-0ab3-50f0-a626-862876b9d5f8,hTERT NF1 ipNF95.6,Cell Line,,RRID:CVCL_UI70,,,,,,,,,,,,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.85,cell_line
384bd83b-5359-5a91-91a2-c02ea3eb23a3,HTS-Luc MPNST,Cell Line,,,,,,,,,,,,,,PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,0.9,cell_line
ecdf2706-b174-572d-9103-02029186533d,Human Foreskin Fibroblast (HFF),Cell Line,,,,,,,,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.8,cell_line
19940322-7115-5e2f-94be-ecc5c28ab7b1,Human meningeal cells (HMC),Cell Line,,,,,,,,,,,,,,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,0.85,cell_line
0db1eb5c-a4d2-5c75-bee1-c3f9e4c42cef,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700)",Cell Line,,,,,,,,,,,,,,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.9,cell_line
02846028-6445-5e63-bba0-8ac632254763,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",Cell Line,,,,,,,,,,,,,,PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,0.9,cell_line
12895209-2ffe-54b9-99eb-02d7c91ae8e6,Human Schwann cells (HSCs),Cell Line,,,,,,,,,,,,,,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.85,cell_line
b4d373d2-fec6-599c-a8e0-85102e5ab336,i18cNF,Cell Line,,,,,,,,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
47a890ce-e8e1-58e9-abd1-396f30119ee4,i21cNF,Cell Line,,,,,,,,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
4bc93c3e-3ee1-52da-b265-85b9b1858403,i28cNF,Cell Line,,RRID:CVCL_B9VA,,,,,,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
df25f9d1-b685-5fff-bc04-de2389b51c64,icNF00.10a,Cell Line,,RRID:CVCL_B9V0,,,,,,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
bb399a47-3006-5d54-8754-c067e5a785a0,icNF04.9a,Cell Line,,RRID:CVCL_B9VC,,,,,,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
c5eab181-010c-53e7-b11e-29b4c9ae3167,icNF97.2a,Cell Line,,RRID:CVCL_B9V3,,,,,,,,,,,,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line
05069634-3b1d-5ad3-9c24-0d974e469302,icNF97.2b,Cell Line,,RRID:CVCL_B9V4,,,,,,,,,,,,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line
69545a99-0d1d-50f0-87d9-9d4b28f1ab5c,icNF98.4c,Cell Line,,RRID:CVCL_B9V7,,,,,,,,,,,,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,0.95,cell_line
6e93c382-29ba-548e-b7cc-c863cd81b98d,icNF98.4d,Cell Line,,RRID:CVCL_B9V8,,,,,,,,,,,,PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,0.95,cell_line
eb060f63-0452-520f-a98b-5e20770c00a3,iHSCs,Cell Line,,,,,,,,,,,,,,PMID:23685747 | PMID:41036607,10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,cell_line
f3d45911-0f4c-54fa-a862-1433f7460f1f,ipn02.3,Cell Line,,RRID:CVCL_UI64,,,,,,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,cell_line
1cec00ad-018a-5e7e-ac4c-9ee63ce76f25,ipn023λ,Cell Line,,,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
3a974d02-5dd6-52a3-b71c-918c878d314a,ipn95.11bC,Cell Line,,,,,,,,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line
1a438aef-29b2-56c9-bf41-08b8b51329fa,ipn97.4 immortalized human Schwann,Cell Line,,,,,,,,,,,,,,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,0.9,cell_line
e4c7659a-3505-5413-aca5-395f2a0c10f8,ipNF02.3 2λ,Cell Line,,,,,,,,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.85,cell_line
3565927d-e858-5eac-aeea-3b0bfad42bdf,ipNF02.8,Cell Line,,,,,,,,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.85,cell_line
99748120-583f-5350-b9f8-cb1231cf4a6b,ipNF03.3,Cell Line,,RRID:CVCL_UI77,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
96120edc-55b3-55fb-a2e0-dd892ef8b39f,ipNF05.5,Cell Line,,RRID:CVCL_UI71,,,,,,,,,,,,PMID:39129390 | PMID:40862755 | PMID:39061138 | PMID:33658640,10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.3390/cancers16142498 | 10.1038/s41416-021-01270-8,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.95,cell_line
e772bcb6-4a3b-5dab-84bd-2f8343f4d285,ipNF05.5 (mixed clone),Cell Line,,RRID:CVCL_UI72,,,,,,,,,,,,PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,0.95,cell_line
0fc4cc7d-3427-5f20-a1f6-b3bf0db9da74,ipNF05.5 (single clone),Cell Line,,,,,,,,,,,,,,PMID:35741605 | PMID:40723243,10.3390/brainsci12060720 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.95,cell_line
288557ae-3aa6-5fe4-b4f2-c31f47d02d5c,ipNF05.5 Mixed Clones,Cell Line,,,,,,,,,,,,,,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.9,cell_line
23b8d261-4be1-5dec-a174-3bc7647bc94f,ipNF05.5-MX,Cell Line,,,,,,,,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line
57fd30a0-521e-59f8-80f1-ddfe31e9c772,ipNF06.2A,Cell Line,,RRID:CVCL_UI74,,,,,,,,,,,,PMID:37164978 | PMID:38136356,10.1038/s41467-023-38432-6 | 10.3390/cancers15245811,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line
f81032de-94dd-5492-98a8-571cd6727fa4,ipNF95.11b C-RFP,Cell Line,,,,,,,,,,,,,,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,0.9,cell_line
abd7894b-6f36-57e2-8cd7-c6ef1e190c68,ipNF95.11b C/T,Cell Line,,RRID:CVCL_UI68,,,,,,,,,,,,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.9,cell_line
decace9b-a0ae-5143-9331-06a492b55a5b,ipNF95.11bC,Cell Line,,RRID:CVCL_UI67,,,,,,,,,,,,PMID:35741605 | PMID:39129390 | PMID:40862755 | PMID:36689660 | PMID:39061138 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.1073/pnas.2208960120 | 10.3390/cancers16142498 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.95,cell_line
c95563a3-6943-5a33-ad3c-23b1c509a267,ipNF95.6,Cell Line,,RRID:CVCL_UI70,,,,,,,,,,,,PMID:35741605 | PMID:33934112 | PMID:33442015 | PMID:38136356,10.3390/brainsci12060720 | 10.1038/s41419-021-03716-6 | 10.1038/s41591-020-01193-6 | 10.3390/cancers15245811,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,0.95,cell_line
db404bea-0054-592e-8ee9-2d9a343749eb,ipnNF09.4,Cell Line,,RRID:CVCL_UI73,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.95,cell_line
bd2c5a12-209e-5172-bb51-6a3eccd64580,ipnNF95.11c,Cell Line,,RRID:CVCL_UI69,,,,,,,,,,,,PMID:35741605 | PMID:39129390 | PMID:38136356 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cancers15245811 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,0.95,cell_line
33501856-51de-5bac-813a-6461cff1afde,iSC,Cell Line,,,,,,,,,,,,,,PMID:38201517 | PMID:18367665,10.3390/cancers16010089 | 10.1124/jpet.107.135830,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.9,cell_line
0e1ef12a-918c-5632-b5ca-6a8d3bff1105,JH-2-002,Cell Line,,,,,,,,,,,,,,PMID:38000020 | PMID:38127282 | PMID:33032988,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548 | 10.1158/0008-5472.CAN-20-1365,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
abf9906f-e801-5772-98d1-23f1ab670210,JH-2-031,Cell Line,,,,,,,,,,,,,,PMID:38000020 | PMID:33032988,10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
4a0443c7-a980-5c3b-9c83-9f42d09127f6,JH-2-079c,Cell Line,,,,,,,,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,cell_line
0d57eb6f-37e3-5c9c-8096-c8703db37579,JH-2-103,Cell Line,,,,,,,,,,,,,,PMID:38000020 | PMID:38127282,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,0.9,cell_line
194c9a0e-18ca-5ebb-9e5e-93a962a93163,JH-2–009,Cell Line,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
e0625198-9dc5-521c-82ef-a61e1158c796,JH-2–055,Cell Line,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
d420daba-7fa5-5556-aa66-a9d02c26af82,JH-2–060,Cell Line,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
220fb2ec-c4d5-52d8-9fc6-8059b1ac6f56,JH-2–074,Cell Line,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
c1327f0c-441a-5f3c-a9e3-5ef76df56153,JH-2–077,Cell Line,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,cell_line
4ee95ac2-12db-5825-b4fc-fb2d8d0726ef,JHH-0879,Cell Line,,,,,,,,,,,,,,PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,0.9,cell_line
82df4dd9-a6dc-5203-920c-ea805bc2b4cf,JHH-136,Cell Line,,RRID:CVCL_VT28,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
49c24d32-1f3e-5e44-8337-d5837d36adae,JHH-520,Cell Line,,RRID:CVCL_VT33,,,,,,,,,,,,PMID:39472976 | PMID:38714355,10.1186/s40478-024-01875-z | 10.1158/1535-7163.MCT-23-0510,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.95,cell_line
0d04bfc5-f3eb-58ae-aba5-96690c0cfbfb,JHU-0879,Cell Line,,RRID:CVCL_VT36,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
02151179-f287-5580-abd5-2ac2cbc4c692,JHU-1016B,Cell Line,,RRID:CVCL_VT40,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
cf536d94-52ae-5b02-b0af-27ea0bcd85aa,JW18.2,Cell Line,,,,,,,,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.85,cell_line
bdaa0134-6ccc-58a1-96fe-06048cca5f31,JW23.3,Cell Line,,,,,,,,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.85,cell_line
6b8fd2c3-41d4-52bf-9a7d-1969f1422589,K4622 grade II glioma,Cell Line,,,,,,,,,,,,,,PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,0.9,cell_line
eacac9ed-5266-56f0-9d8b-38b1b0c9ba6a,K562,Cell Line,,,,,,,,,,,,,,PMID:23685747 | PMID:40025578,10.1038/ng.2641 | 10.1186/s40478-025-01965-6,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line
e0c247ed-04f8-5270-bb80-c82f5b38bcaf,KT21-MG1,Cell Line,,RRID:CVCL_M429,,,,,,,,,,,,PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,0.9,cell_line
9111df47-6a9a-5c46-b54f-0661751f2960,LLC-PK1 ATCC CL-101,Cell Line,,,,,,,,,,,,,,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,0.85,cell_line
c865f818-8228-57eb-84d6-b7a24593eab1,LN229,Cell Line,,RRID:CVCL_0393,,,,,,,,,,,,PMID:41022755 | PMID:38714355,10.1038/s41467-025-63619-4 | 10.1158/1535-7163.MCT-23-0510,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.9,cell_line
299a9e12-545a-533a-9848-39f085721fd1,LN319,Cell Line,,RRID:CVCL_3958,,,,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.9,cell_line
7381a36e-0cd3-5b7d-9b6e-553506c81e7b,LN428 human glioblastoma multiforme (GBM),Cell Line,,,,,,,,,,,,,,PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,0.85,cell_line
66c70328-85a9-5e0d-8042-37528bd5f087,LS141,Cell Line,,RRID:CVCL_M823,,,,,,,,,,,,PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.8,cell_line
b55bee8c-2e29-594b-8678-d3325c18143b,LUVA,Cell Line,,RRID:CVCL_5G48,,,,,,,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.85,cell_line
6e020ba9-4b89-51e0-9869-af3bb72e39da,lymphoblastoid,Cell Line,,,,,,,,,,,,,,PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,0.85,cell_line
58572cd5-257d-5a91-bce4-c2b350c55e81,M1,Cell Line,,RRID:CVCL_2107,,,,,,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
0ba2fe44-41b5-5a53-a55e-9b75fe5f1d68,M3,Cell Line,,RRID:CVCL_4Y25,,,,,,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
4f4adb1b-8529-58fe-aa4c-3a99cf63acf0,M308,Cell Line,,RRID:CVCL_D766,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
05ae7018-8e02-56bf-9b5e-d339b1e441a0,M4,Cell Line,,RRID:CVCL_E9VC,,,,,,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
cd2834e1-9e2b-5a0b-9a96-6836b5a86c8d,M5,Cell Line,,RRID:CVCL_WH33,,,,,,,,,,,,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line
d81d9712-f258-51b8-8278-78cc50900055,M6,Cell Line,,RRID:CVCL_A4AU,,,,,,,,,,,,PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,0.95,cell_line
c5e9a426-fca1-5185-a52f-ddccbacfdd9b,M724,Cell Line,,RRID:CVCL_8916,,,,,,,,,,,,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,0.95,cell_line
7d3dba55-ca50-511a-be1d-8470c1224b70,MCF10A,Cell Line,,,,,,,,,,,,,,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,0.85,cell_line
7009c225-cd7f-57a0-adb2-d1a86b112043,MCF7,Cell Line,,,,,,,,,,,,,,PMID:38216123 | PMID:40507334,10.1016/j.molmet.2024.101876 | 10.3390/cancers17111852,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,0.9,cell_line
5d1eb25f-d9d0-56d8-9d0d-c231ac92a03e,Meso-33,Cell Line,,,,,,,,,,,,,,PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,0.9,cell_line
6cc5b753-3c9d-58f2-a150-c8734abe04eb,MiaPaCa-2,Cell Line,,RRID:CVCL_0428,,,,,,,,,,,,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,cell_line
5b905bbc-dcc8-56fe-940b-3441008c4e1e,MN1-LF,Cell Line,,,,,,,,,,,,,,PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,0.85,cell_line
441c9238-67d2-506c-a607-419d96a3b689,mouse embryonic fibroblasts (MEFs),Cell Line,,,,,,,,,,,,,,PMID:28392281 | PMID:34065204,10.1016/j.expneurol.2017.04.001 | 10.3390/ijms22105367,Human stem cell modeling in neurofibromatosis type 1 (NF1). | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,0.9,cell_line
318750a4-ea8b-515a-bd7a-76c3784c36c3,"Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",Cell Line,,,,,,,,,,,,,,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,0.9,cell_line
5512de2b-3b60-5754-9efc-425090e750d2,MPNST,Cell Line,,,,,,,,,,,,,,PMID:24509877 | PMID:18413802,10.1038/onc.2013.506 | 10.1158/1535-7163.MCT-07-0518,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,0.9,cell_line
0bb4db3d-95b6-5372-808a-c6704a2625bd,MPNST 88-14,Cell Line,,,,,,,,,,,,,,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.95,cell_line
73a99a79-c7e0-561a-b064-359aed15bc81,MPNST S462-TY,Cell Line,,,,,,,,,,,,,,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.95,cell_line
8d54897a-5c5d-523b-b534-4b2e8aa80286,MPNST-NF1-08,Cell Line,,,,,,,,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
17bbbdea-39a6-5035-9fab-edd9c988df07,MPNST-NF1-9,Cell Line,,,,,,,,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
40210d2d-9336-51b4-b9db-f804f59a70bd,MPNST-SP-01,Cell Line,,,,,,,,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
64ee8b55-8367-5ff0-acb6-49e2897955e6,MPNST642,Cell Line,,RRID:CVCL_AU19,,,,,,,,,,,,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,0.9,cell_line
fb87168e-a32f-5220-b2d2-5464417de4b0,murine NF2 −/− Schwann,Cell Line,,,,,,,,,,,,,,PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,0.9,cell_line
6e520e64-5b89-505e-b1c6-b07c0d2d47aa,NCI-H266,Cell Line,,,,,,,,,,,,,,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,0.8,cell_line
e4274a5c-5e95-5610-aeb8-5fa130b1f8c4,Neural stem,Cell Line,,,,,,,,,,,,,,PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,0.8,cell_line
d801b6e8-d449-515a-93ad-5d8e0133ae7d,Neurofibromatosis 1 fibroblasts,Cell Line,,,,,,,,,,,,,,PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,0.85,cell_line
dc65eb71-c590-5a4f-b241-ddd888075c31,NF02.2,Cell Line,,,,,,,,,,,,,,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,0.9,cell_line
2161e9dc-dc78-5518-a26b-b35422575e49,Nf1 flox/flox calvaria osteoblasts,Cell Line,,,,,,,,,,,,,,PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,0.8,cell_line
f31b01d0-5fd9-59a8-b044-3665fe3e9236,NF1-/- iPSC-derived neural crest,Cell Line,,,,,,,,,,,,,,PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,0.85,cell_line
ffd2b57e-8920-5631-9047-ef384b8e5fd3,Nf1-/- mouse embryo fibroblasts,Cell Line,,,,,,,,,,,,,,PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,0.9,cell_line
1760a885-37db-59e7-a79d-b0749772a6d8,NF1-1 hiPSC line,Cell Line,,,,,,,,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.9,cell_line
f06517b7-580b-5060-8de6-1918e745f09d,NF1-2 hiPSC line,Cell Line,,,,,,,,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.9,cell_line
f6f389ee-1913-5b51-9e9d-60718392f57d,NF10.1,Cell Line,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
6cd8aa27-1517-5cb7-9ccc-c3776d7be0c1,NF11.1,Cell Line,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
2cfe2fe7-e0f5-5eec-8a23-6ca6e83eb7ad,Nf1flox/flox bone marrow stromal,Cell Line,,,,,,,,,,,,,,PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,0.8,cell_line
e2b415f7-c74a-5407-92da-98802525b0d2,"NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12",Cell Line,,,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
3b885fc6-2b81-5135-b19d-41858172ab16,NF2 primary fibroblasts,Cell Line,,,,,,,,,,,,,,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,0.9,cell_line
ef45ea0c-0c92-5916-b2bb-3e9c6f13c3ac,Nf2-deficient spinal cord neural progenitor,Cell Line,,,,,,,,,,,,,,PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,0.9,cell_line
9fad9960-2016-5753-9866-0c939222bcd5,NF37,Cell Line,,,,,,,,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
9e1f94af-229c-5c37-aabe-d5db89723c2e,NF87,Cell Line,,,,,,,,,,,,,,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,0.85,cell_line
2859c032-ab81-5e1e-b05c-9043e10e6982,NF90-8,Cell Line,,RRID:CVCL_1B47,,,,,,,,,,,,PMID:18367665 | PMID:33658640 | PMID:33032988,10.1124/jpet.107.135830 | 10.1038/s41416-021-01270-8 | 10.1158/0008-5472.CAN-20-1365,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.95,cell_line
3273be64-f8a9-5cdc-a01b-c94dc69dd748,NF94.3,Cell Line,,,,,,,,,,,,,,PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
4759e8ba-b29a-58eb-bad8-160f243e4f6e,NF95.11b,Cell Line,,,,,,,,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line
6c3cc53f-b3e5-58dc-bbe2-f0a8d11e9a76,NF95.6,Cell Line,,,,,,,,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line
c1d72c0c-37a9-5f45-9603-2afdf01969a8,NF96.2,Cell Line,,,,,,,,,,,,,,PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,cell_line
e9cebee0-b3a6-597f-8b44-15271a6f53a4,NGT-41,Cell Line,,,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
901d010a-831b-5221-a14a-3fd465e9c1de,NIH-3T3,Cell Line,,RRID:CVCL_0594,,,,,,,,,,,,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,0.9,cell_line
96057038-9982-57a5-b50d-b4f8dd789948,NMCG-1,Cell Line,,RRID:CVCL_1608,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.85,cell_line
3254ce41-7862-57ab-935c-4b6f282d4738,Normal human Schwann cells (HSC),Cell Line,,,,,,,,,,,,,,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,0.85,cell_line
6793aaa0-c35a-5164-83b3-10692471e87a,Normal human Schwann cells (NHSC),Cell Line,,,,,,,,,,,,,,PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,0.85,cell_line
0e0df540-0cd5-5dcc-863f-c5726016888b,Normal human Schwann cells (Sciencell),Cell Line,,,,,,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.9,cell_line
41f3ec49-a3df-56a8-be13-329fac246519,NPcis,Cell Line,,,,,,,,,,,,,,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,0.95,cell_line
a294f2eb-af7f-5ab4-887a-5bc0b414a9bb,NSF1,Cell Line,,,,,,,,,,,,,,PMID:41001593 | PMID:32948135,10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,0.9,cell_line
aaed50c9-2844-5c59-bfc5-5c78ade18117,OLN93 mouse oligodendrocyte,Cell Line,,,,,,,,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line
6d101a5b-0f0e-5148-91f6-8e033fd471ce,optic glioma,Cell Line,,,,,,,,,,,,,,PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,0.8,cell_line
26bcc0da-c9e4-572f-b1a0-03894867affa,PANC1,Cell Line,,RRID:CVCL_0480,,,,,,,,,,,,PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,cell_line
9c2a04f2-e089-5e02-9ca9-9469e88a1762,PNF-derived Schwann,Cell Line,,,,,,,,,,,,,,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,0.85,cell_line
5caa5d42-6319-50cd-aebb-631e7ec3962c,pNF9511bc,Cell Line,,,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
c60fdd8e-c993-5ad6-874b-29c519f3858c,primary human Schwann cells (HSC),Cell Line,,,,,,,,,,,,,,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,0.85,cell_line
fa2d697c-87d5-5ca6-8521-55dfc7fcb50f,Primary human vestibular schwannoma (VS) cell cultures,Cell Line,,,,,,,,,,,,,,PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,0.9,cell_line
59af1a48-5ee8-5532-90c0-5083623295ab,Primary normal rat Schwann,Cell Line,,,,,,,,,,,,,,PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,0.85,cell_line
16a60b64-483c-518a-abae-07c189adef81,RHT92,Cell Line,,,,,,,,,,,,,,PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,0.9,cell_line
99356176-3cc2-5af4-a888-42ba353f379c,Rosetta2(DE3) competent,Cell Line,,,,,,,,,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,0.85,cell_line
7f248fad-3eba-5240-9e11-aae2a861d9c8,RT4-D6P2T schwannoma,Cell Line,,,,,,,,,,,,,,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.9,cell_line
df57cf04-e722-55e4-9965-40dee2f876d6,RT4-D6PT2 schwannoma,Cell Line,,,,,,,,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line
61206236-fde5-5b73-b1d5-307009cd177c,S462,Cell Line,,RRID:CVCL_1Y70,,,,,,,,,,,,PMID:41022755 | PMID:32383545 | PMID:33658640 | PMID:38502231 | PMID:23328114 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:41001593 | PMID:32948135 | PMID:37410426 | PMID:23535903 | PMID:35511749,10.1038/s41467-025-63619-4 | 10.15252/embr.201949117 | 10.1038/s41416-021-01270-8 | 10.1172/JCI176748 | 10.18632/oncotarget.793 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947,"Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.",,0.95,cell_line
906fc06b-68d4-5355-ae14-f8a175ea9cb3,S462TY,Cell Line,,RRID:CVCL_JK02,,,,,,,,,,,,PMID:38201517 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:41036607 | PMID:38203448 | PMID:23535903,10.3390/cancers16010089 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.95,cell_line
622ddce9-3f48-5a21-8b4a-bbc4ea4219c2,S520,Cell Line,,RRID:CVCL_AX35,,,,,,,,,,,,PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
3a050b9b-f50a-50e0-82be-af5580a2bcc1,SC4-immortalized Nf2-/- primary Schwann,Cell Line,,,,,,,,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.95,cell_line
45e82643-6f9d-5f5a-842e-b288e3703d7f,Schwann,Cell Line,,,,,,,,,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.9,cell_line
5d82da91-d47d-578b-9ce7-5bce5028b878,Sf9,Cell Line,,RRID:CVCL_0549,,,,,,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
7d07e1d2-fe8d-57ac-9d87-7f4040b54729,SNF02.2,Cell Line,,RRID:CVCL_K280,,,,,,,,,,,,PMID:29438698 | PMID:38216572,10.1016/j.ccell.2018.01.005 | 10.1038/s41467-024-44755-9,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.95,cell_line
cda1c13a-47d6-5e8a-933f-805a61108d62,SNF94.3,Cell Line,,RRID:CVCL_K164,,,,,,,,,,,,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.9,cell_line
14909473-2fb4-5ed1-b829-ff132be20653,SNF96.2,Cell Line,,RRID:CVCL_K281,,,,,,,,,,,,PMID:39269317 | PMID:23175151 | PMID:29438698 | PMID:40025578 | PMID:36322658 | PMID:35511749 | PMID:32642733 | PMID:38216572,10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1016/j.ccell.2018.01.005 | 10.1186/s40478-025-01965-6 | 10.1126/sciadv.abo5442 | 10.1158/1535-7163.MCT-21-0947 | 10.1093/noajnl/vdz061 | 10.1038/s41467-024-44755-9,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,0.95,cell_line
733801bc-7188-503b-8116-384c9879b9f3,ST88-14,Cell Line,,RRID:CVCL_8916,,,,,,,,,,,,PMID:38201517 | PMID:41022755 | PMID:39269317 | PMID:18367665 | PMID:37246765 | PMID:33658640 | PMID:24824755 | PMID:39129390 | PMID:18413802 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:38216572 | PMID:38203448 | PMID:23535903 | PMID:41036607 | PMID:33032988,10.3390/cancers16010089 | 10.1038/s41467-025-63619-4 | 10.1158/1078-0432.CCR-24-1750 | 10.1124/jpet.107.135830 | 10.1093/neuonc/noad097 | 10.1038/s41416-021-01270-8 | 10.1371/journal.pone.0096733 | 10.1002/1878-0261.13704 | 10.1158/1535-7163.MCT-07-0518 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1038/s41467-024-44755-9 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-24-1053 | 10.1158/0008-5472.CAN-20-1365,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,0.95,cell_line
d101dfd6-6d34-512a-8c60-671a059abad3,ST88-3,Cell Line,,RRID:CVCL_IU70,,,,,,,,,,,,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
857f7dbe-27ac-5f60-80de-aa12f7080a95,STS26T,Cell Line,,RRID:CVCL_8917,,,,,,,,,,,,PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38203448 | PMID:37410426 | PMID:23535903 | PMID:35511749 | PMID:33032988,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.3390/ijms25010277 | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947 | 10.1158/0008-5472.CAN-20-1365,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,0.9,cell_line
33995551-b2f8-566f-bbba-cb638a12ba6b,T265,Cell Line,,RRID:CVCL_S805,,,,,,,,,,,,PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:41001593 | PMID:38203448 | PMID:32948135 | PMID:23535903,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1080/23723556.2025.2561292 | 10.3390/ijms25010277 | 10.1186/s12885-020-07397-w | 10.1158/2159-8290.CD-13-0081,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,0.9,cell_line
bcd30b69-1586-5ceb-abe5-4b9e19466fe4,T265-2c,Cell Line,,RRID:CVCL_S805,,,,,,,,,,,,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,0.9,cell_line
d6faa9df-da18-5590-9ecc-1f9eee8532f9,T265p21,Cell Line,,RRID:CVCL_S805,,,,,,,,,,,,PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
3549582f-ff39-5bfd-9c26-00e57d7805ae,T98G,Cell Line,,RRID:CVCL_0556,,,,,,,,,,,,PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,0.8,cell_line
ac5786d9-0742-5caf-a7fc-62296288ec15,tail-tip fibroblasts (TTFs),Cell Line,,,,,,,,,,,,,,PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,,0.9,cell_line
520833a7-34e9-5a8b-aa08-c19e79dc0612,TC620 human oligodendroglioma,Cell Line,,,,,,,,,,,,,,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,0.9,cell_line
274be0a0-e9df-5860-8892-72cb9887d099,TM-31,Cell Line,,RRID:CVCL_6735,,,,,,,,,,,,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,0.95,cell_line
295395e8-095c-58b4-bd92-9b5178a341a4,Tni-FNL,Cell Line,,RRID:CVCL_RY32,,,,,,,,,,,,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,0.9,cell_line
90ede777-afc9-5311-b681-ce6333eae4cb,TOP-10F',Cell Line,,,,,,,,,,,,,,PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,0.85,cell_line
07eab8f2-f28c-5ea9-b326-a0c94aa93543,U251,Cell Line,,RRID:CVCL_0021,,,,,,,,,,,,PMID:32419643 | PMID:33934112 | PMID:25043298,10.1177/1533033820919759 | 10.1038/s41419-021-03716-6 | 10.1038/onc.2014.185,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,cell_line
13cfbf4b-7b85-5529-81fd-0799e3d00ab7,U2OS,Cell Line,,RRID:CVCL_0042,,,,,,,,,,,,PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,0.85,cell_line
9bffcee2-110a-5f30-a83f-5349091ab434,U87-MG,Cell Line,,RRID:CVCL_0022,,,,,,,,,,,,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,0.95,cell_line
2286ee1a-9330-5bf4-ab3c-c46362e5d070,WM3918,Cell Line,,RRID:CVCL_C279,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.85,cell_line
00a4afb5-a6d7-5227-9041-942a7781cddc,WT-1 hiPSC line,Cell Line,,,,,,,,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.85,cell_line
6ea53b58-c0ec-519b-8b9d-eff75a906795,WT-2 hiPSC line,Cell Line,,,,,,,,,,,,,,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,0.85,cell_line
73fcc875-6ee3-59bb-8aa3-9fe75b50d858,YST1,Cell Line,,,,,,,,,,,,,,PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,0.9,cell_line
e569d9f6-0608-5741-ba68-3259feacc272,φNX packaging,Cell Line,,,,,,,,,,,,,,PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,0.85,cell_line
bd963f64-921c-550d-9232-3c624b167c15,BoN (Burden of NF1) questionnaire,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.95,clinical_assessment_tool
e4d24f91-9ec0-5c15-bccb-11594e0f2602,Cardiff acuity cards,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
57f38f1c-aef0-5b8b-a0d6-1150edeeab07,Cirrus HD-OCT,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool
41690aa7-93cc-5c85-8579-9367d647b0b1,cNF-Skindex,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,0.95,clinical_assessment_tool
d3b1dfbf-71ee-5e64-aa45-833969852d65,Dermatology Life Quality Index (DLQI),Clinical Assessment Tool,,,,,,,,,,,,,,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.9,clinical_assessment_tool
cbb461af-25d6-591f-864c-b4808d7d6989,Humphrey Field Analyzer perimetry,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool
8d085b33-a06f-5476-957f-c1d438011c8c,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,,0.95,clinical_assessment_tool
dd140fcf-1389-5b90-94da-8978ca70bf86,KM (Konstantin Moutakis) cards,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
71b9e485-eb19-5321-b8b5-cccda706fe04,Lea cards,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
5b689dd7-5fc9-567b-9415-ba38fc1d245c,Likert scale questionnaire,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,0.85,clinical_assessment_tool
1b6e2a2a-af7b-595c-ac77-fca8a5b13e5d,PlexiQoL,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:33085177 | PMID:38499890,10.1002/mgg3.1530 | 10.1186/s41687-024-00714-y,"The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas. | The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,0.95,clinical_assessment_tool
cd5ce5c7-6228-5faf-9949-4ca03c7e99c1,SF12,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,0.9,clinical_assessment_tool
36ba0734-10fe-5733-b761-fed8ba10b043,Teller acuity cards,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.85,clinical_assessment_tool
814144de-175f-512e-9299-125ece9cc7e4,World Health Organization Categories of Childhood VI scale,Clinical Assessment Tool,,,,,,,,,,,,,,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,0.9,clinical_assessment_tool
4a49f884-8997-5884-939d-d32a027ba173,DINs (Deep Interactive Networks),Computational Tool,,,,,,,,,,,,,,PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,0.95,computational_tool
f6f44b1b-1184-59e7-83fd-bc9eade2284f,RENOVO-NF1,Computational Tool,,,,,,,,,,,,,,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,0.95,computational_tool
7efb0f81-781b-508c-8b51-bd1bc42050d0,1276P NF1 GRD,Genetic Reagent,,,,,,,,,,,,,,PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,0.9,genetic_reagent
3e26c266-237c-50ce-bf42-389a5d88cff1,Cas9 and sgRNAs targeting Nf1+Cdkn2a,Genetic Reagent,,,,,,,,,,,,,,PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,0.9,genetic_reagent
6a54cddc-272f-5cfc-b063-48f9969606ab,dNf1,Genetic Reagent,,,,,,,,,,,,,,PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,0.9,genetic_reagent
e27b27fb-155e-5921-902e-5e9db24a264a,HA-Merlin,Genetic Reagent,,,,,,,,,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,genetic_reagent
2af24a58-4a08-5f34-b39a-00372f6d22a8,human neurofibromin,Genetic Reagent,,,,,,,,,,,,,,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,0.95,genetic_reagent
83ecd84b-4ddc-52b4-9b65-26baf7f4e30d,Merlin,Genetic Reagent,,,,,,,,,,,,,,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,0.9,genetic_reagent
58f25ef1-d11b-59e3-9649-436ff28ce3e7,Merlin isoform 1,Genetic Reagent,,,,,,,,,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,0.85,genetic_reagent
cbc093da-7e68-5b32-818b-f5c9fa24b551,Merlin siRNA,Genetic Reagent,,,,,,,,,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.85,genetic_reagent
35b70a2e-944e-5366-90e3-312dccf7dd9b,Merlin(S518D) and Merlin(S518E) mutants,Genetic Reagent,,,,,,,,,,,,,,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,0.8,genetic_reagent
a7926f94-fdf4-5cc2-8b55-e3a892f2de94,neurofibromin 2,Genetic Reagent,,,,,,,,,,,,,,PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,0.95,genetic_reagent
182aad93-5fa7-51dc-b298-2c359c28371f,Nf1,Genetic Reagent,,,,,,,,,,,,,,PMID:32461556 | PMID:38481529 | PMID:39890807 | PMID:34646065 | PMID:37446790 | PMID:34011935 | PMID:29670214 | PMID:37140985 | PMID:36241865,10.1038/s41467-020-16432-0 | 10.3389/fcell.2024.1359561 | 10.1038/s41598-024-84493-y | 10.1155/2021/9386823 | 10.3390/molecules28135128 | 10.1038/s41419-021-03802-9 | 10.1038/s41598-018-24310-5 | 10.1172/JCI168227 | 10.1038/s12276-022-00850-9,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Survival and | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Restoring functional neurofibromin by protein transduction. | Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,0.95,genetic_reagent
6aef8f45-05fd-54b2-a19a-73f1688f586e,NF1 capture probes,Genetic Reagent,,,,,,,,,,,,,,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,0.9,genetic_reagent
01acf277-b66a-501f-9790-86b8b22e9a4a,NF1 DLR,Genetic Reagent,,,,,,,,,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.95,genetic_reagent
fce11210-d4af-59a8-9332-478ee203fab0,Nf1 flox,Genetic Reagent,,,,,,,,,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.95,genetic_reagent
bca1003e-cc07-5aef-bafa-63c5c19414f9,NF1 gRNA,Genetic Reagent,,,,,,,,,,,,,,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,0.85,genetic_reagent
06cfd3ee-3729-5709-b480-369992a65417,NF1 isoform 2,Genetic Reagent,,RRID:Addgene_70423,,,,,,,,,,,,PMID:31836666 | PMID:36689660,10.1074/jbc.RA119.010934 | 10.1073/pnas.2208960120,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,0.9,genetic_reagent
9eac762d-fe39-5dd6-92f3-8ef4b951e1c2,Nf1 KO,Genetic Reagent,,,,,,,,,,,,,,PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,0.9,genetic_reagent
e38aa0ec-2c20-56e8-a848-a9dc9af01121,NF1-GRD,Genetic Reagent,,,,,,,,,,,,,,PMID:24509877 | PMID:35393510 | PMID:16835260 | PMID:38000020,10.1038/onc.2013.506 | 10.1038/s41418-022-00991-4 | 10.1093/hmg/ddl165 | 10.1126/sciadv.adg8876,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,genetic_reagent
47c4dd20-2b55-5df4-8b68-67057a9b3504,NF1-targeting TALEN,Genetic Reagent,,,,,,,,,,,,,,PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,0.85,genetic_reagent
c732c818-394c-51d3-99d5-c960a3514166,NF2,Genetic Reagent,,,,,,,,,,,,,,PMID:33273014 | PMID:29715273 | PMID:30274821 | PMID:26219339 | PMID:24595234,10.1074/jbc.RA120.014960 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.18632/oncotarget.4858 | 10.1371/journal.pone.0090853,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,0.9,genetic_reagent
cb62b06d-517e-5577-b058-c6dc50f63e15,NF2 shRNA,Genetic Reagent,,,,,,,,,,,,,,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,0.9,genetic_reagent
31ce5396-5fef-5952-973a-b36931af7123,NF2 TET,Genetic Reagent,,,,,,,,,,,,,,PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,0.85,genetic_reagent
6f302b53-8c6e-5217-b02e-577bc50d14fe,nf2a/b-4sgRNA,Genetic Reagent,,,,,,,,,,,,,,PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,0.85,genetic_reagent
f650c0fa-4167-5038-a70d-c72ac33d2495,S518A HA-Merlin,Genetic Reagent,,,,,,,,,,,,,,PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,,0.9,genetic_reagent
31f7668c-a012-593c-8da4-f3cd33132a7f,shNF1,Genetic Reagent,,,,,,,,,,,,,,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,0.95,genetic_reagent
c97c2874-6530-5a9f-be63-3228031d0f39,SPRED1,Genetic Reagent,,,,,,,,,,,,,,PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,0.85,genetic_reagent
9762d0c4-3a1e-5b5f-bcb2-68b7de13fc26,Spred1(EVH1),Genetic Reagent,,,,,,,,,,,,,,PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,0.85,genetic_reagent
22f0b8cc-5350-5fc3-82cc-8d0db0767a1b,Cutaneous neurofibroma samples,Patient-Derived Model,,,,,,,,,,,,,,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,0.9,patient_derived_model
e3eae52e-f08c-50ac-a9cf-1cf261cce77e,human neurofibroma xenografts,Patient-Derived Model,,,,,,,,,,,,,,PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,0.9,patient_derived_model
a238b29c-bfe1-5abe-9f2e-f019bf145305,JH-2-002,Patient-Derived Model,,,,,,,,,,,,,,PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
df878292-d243-5bc5-8fe0-1c11a30decb5,JH-2-031,Patient-Derived Model,,,,,,,,,,,,,,PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
0ad52ce6-3d08-5eae-afa7-4070c3f917b1,JH-2-079c,Patient-Derived Model,,,,,,,,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
eb1ec3b8-3373-56da-811c-35ba7f43da05,MN-2,Patient-Derived Model,,RRID:CVCL_E781,,,,,,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
64903d54-1f35-5c00-90d5-9dae1f854021,MN-3-002,Patient-Derived Model,,,,,,,,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
1a1e5f49-9944-5fdc-a2bc-507f5a611d38,MPNST-NF1-09,Patient-Derived Model,,,,,,,,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
878e2a16-a7c0-52f0-aae3-604a82662542,MPNST-SP-01,Patient-Derived Model,,,,,,,,,,,,,,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,0.9,patient_derived_model
14e76c31-31f8-5251-91e2-27ee74b3d931,NF90.8,Patient-Derived Model,,,,,,,,,,,,,,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,0.9,patient_derived_model
98820301-8821-5496-8914-0f29af4bac44,Patient-derived xenograft (PDX) MPNST model,Patient-Derived Model,,,,,,,,,,,,,,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,0.9,patient_derived_model
6a3d4fbb-c8ee-5d95-8b3d-f0b5b3991295,RHT-92,Patient-Derived Model,,,,,,,,,,,,,,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,0.9,patient_derived_model
05082e19-1068-552d-b41a-8de52c52fc44,vestibular schwannoma xenografts,Patient-Derived Model,,,,,,,,,,,,,,PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,0.9,patient_derived_model
8f471752-d637-59f2-9b80-30d1566f673a,WU-225,Patient-Derived Model,,,,,,,,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
18cdb28b-9cef-51f5-b411-2b0939e0724d,WU-386,Patient-Derived Model,,,,,,,,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
457d0b4b-25ae-5a5d-8dfc-f9cc116069aa,WU-545,Patient-Derived Model,,,,,,,,,,,,,,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,0.9,patient_derived_model
